Elutia Inc.
ELUT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708527
No open-market purchases or sales by Elutia Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Elutia Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +2 vs. Q3 2025
- Shares held
- 16.1M
- −1.97M (−10.9%) vs. Q3 2025
- Total value
- $11.1M
- −$4.93M (−30.7%) vs. Q3 2025
- New holders
- 5
- 6 more added
- Sold out
- 3
- 13 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELUT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $13.8M |
| Q1 2026 | 35 | $16.0M |
| Q4 2025 | 33 | $11.1M |
| Q3 2025 | 31 | $16.1M |
| Q2 2025 | 28 | $34.4M |
| Q1 2025 | 31 | $43.6M |
| Q4 2024 | 32 | $49.3M |
| Q3 2024 | 29 | $46.7M |
| Q2 2024 | 26 | $44.5M |
| Q1 2024 | 22 | $17.9M |
| Q4 2023 | 24 | $14.9M |
| Q3 2023 | 21 | $9.20M |
| Q2 2023 | 19 | $7.23M |
| Q1 2023 | 18 | $4.20M |
| Q4 2022 | 19 | $18.4M |
| Q3 2022 | 17 | $24.0M |
| Q2 2022 | 17 | $23.6M |
| Q1 2022 | 17 | $19.4M |
| Q4 2021 | 15 | $19.8M |
| Q3 2021 | 17 | $13.2M |
| Q2 2021 | 24 | $19.7M |
| Q1 2021 | 31 | $23.5M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Elutia Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 7 | $5 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 22 | $15 | 0.00% | −23,589−99.9% | Reduced |
| UBS Group AG | 29 | $20 | 0.00% | −192−86.9% | Reduced |
| SBI Securities Co., Ltd. | 55 | $38 | 0.00% | −1−1.8% | Reduced |
| Wells Fargo & Company | 1,600 | $1.11K | 0.00% | −3,500−68.6% | Reduced |
| Tower Research Capital LLC (TRC) | 6,246 | $4.33K | 0.00% | +986+18.7% | Added |
| Morgan Stanley | 7,971 | $5.52K | 0.00% | 00.0% | Unchanged |
| Family Management Corp | 10,045 | $6.96K | 0.00% | +10,045 | New |
| State Street Corp | 11,969 | $8.29K | 0.00% | 00.0% | Unchanged |
| Indie Asset Partners, LLC | 12,612 | $8.74K | 0.01% | +12,612 | New |
| Millennium Management LLC | 12,870 | $8.91K | 0.00% | −17,919−58.2% | Reduced |
| Tufton Capital Management | 14,550 | $10.0K | 0.00% | +850+6.2% | Added |
| Verdence Capital Advisors LLC | 19,410 | $13.4K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 20,178 | $14.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 23,233 | $16.0K | 0.00% | −995−4.1% | Reduced |
| Northern Trust Corp | 27,662 | $19.2K | 0.00% | 00.0% | Unchanged |
| Arcus Capital Partners, LLC | 30,050 | $20.8K | 0.01% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 37,000 | $25.0K | 0.01% | +37,000 | New |
| Jane Street Group, LLC | 47,266 | $32.7K | 0.00% | −21,118−30.9% | Reduced |
| Rossmore Private Capital | 50,000 | $34.6K | 0.00% | +50,000 | New |
| Renaissance Technologies LLC | 102,116 | $70.7K | 0.00% | +40,123+64.7% | Added |
| XTX Topco Ltd | 102,504 | $71.0K | 0.00% | +102,504 | New |
| BlackRock, Inc. | 102,987 | $71.3K | 0.00% | +2,340+2.3% | Added |
| Citadel Advisors LLC | 154,053 | $106.7K | 0.00% | +97,449+172.2% | Added |
| Geode Capital Management, LLC | 255,212 | $176.8K | 0.00% | 00.0% | Unchanged |
| Birchview Capital, LP | 263,018 | $182.2K | 0.11% | −448,157−63.0% | Reduced |
| Perkins Capital Management Inc | 780,594 | $540.7K | 0.43% | −350,905−31.0% | Reduced |
| Vanguard Group Inc | 1,157,484 | $802.1K | 0.00% | −23,021−2.0% | Reduced |
| Alyeska Investment Group, L.P. | 1,281,172 | $887.5K | 0.00% | −1,362,273−51.5% | Reduced |
| Knollwood Investment Advisory, LLC | 2,556,724 | $1.77M | 0.17% | +1,525,157+147.8% | Added |
| Silverarc Capital Management, LLC | 2,751,314 | $1.91M | 0.28% | −99,673−3.5% | Reduced |
| AIGH Capital Management LLC | 3,068,185 | $2.13M | 0.63% | −96,943−3.1% | Reduced |
| Nantahala Capital Management, LLC | 3,184,947 | $2.21M | 0.13% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −1,371,603−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −29,598−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |